Alon Gurfinkel

Davis Polk advised Soltec Power Holdings, S.A. on the Rule 144A/Regulation S initial public offering by Soltec Power Holdings of 31,146,717 of its ordinary shares. The initial public…

Davis Polk advised Delek Overriding Royalty Leviathan Ltd., on its Rule 144A offering of $180 million principal amount of 7.494% senior secured notes due 2023. The notes are secured by…

Davis Polk advised the underwriters in connection with a Regulation S offering by Hubei Science & Technology Investment Group (Hong Kong) Company Limited, a wholly owned subsidiary of…

Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.  Xspray was founded in 2003…

Davis Polk advised Celonis SE on its acquisition of Integromat s.r.o. Financial terms of the transaction were not disclosed. Celonis, headquartered in Munich and New York, is a market…

Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…

Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $650 million 1.720% notes due 2026 and $300 million 2.375% notes due 2030.Baidu, Inc. is a leading…

Davis Polk advised the dealer managers in connection with Empresa Eléctrica Angamos SpA’s cash tender offer for up to the outstanding $388 million aggregate principal amount of its 4.875%…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of 2.807% senior notes due 2050 by…

Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …